Author
Listed:
- Yuxiao Deng
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Zhongwei Yang
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Toya Terry
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Su Pan
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Darren G. Woodside
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Jingxiong Wang
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Kehe Ruan
(University of Houston)
- James T. Willerson
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Richard A. F. Dixon
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
- Qi Liu
(Wafic Said Molecular Cardiology Research Laboratory, Texas Heart Institute)
Abstract
Promoting the paracrine effects of human mesenchymal stem cell (hMSC) therapy may contribute to improvements in patient outcomes. Here we develop an innovative strategy to enhance the paracrine effects of hMSCs. In a mouse hindlimb ischaemia model, we examine the effects of hMSCs in which a novel triple-catalytic enzyme is introduced to stably produce prostacyclin (PGI2-hMSCs). We show that PGI2-hMSCs facilitate perfusion recovery and enhance running capability as compared with control hMSCs or iloprost (a stable PGI2 analogue). Transplanted PGI2-hMSCs do not incorporate long term into host tissue, but rather they mediate host regeneration and muscle mass gain in a paracrine manner. Mechanistically, this involves long noncoding RNA H19 in promoting PGI2-hMSC-associated survival and proliferation of host progenitor cells under hypoxic conditions. Together, our data reveal the novel ability of PGI2-hMSCs to stimulate host regenerative processes and improve physical function by regulating long noncoding RNA in resident progenitor cells.
Suggested Citation
Yuxiao Deng & Zhongwei Yang & Toya Terry & Su Pan & Darren G. Woodside & Jingxiong Wang & Kehe Ruan & James T. Willerson & Richard A. F. Dixon & Qi Liu, 2016.
"Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia,"
Nature Communications, Nature, vol. 7(1), pages 1-12, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11276
DOI: 10.1038/ncomms11276
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11276. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.